Ovarian cancer: Not a silent killer

BMJ (Online)

Volumn 339, Issue 7713, 2009, Pages 123-

  Hamilton, William ^a   Round, Alison ^b   Sharp, Debbie ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Castle Place Practice ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

CANCER DIAGNOSIS; CANCER SCREENING; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); DELAYED DIAGNOSIS; ECHOGRAPHY; EMOTION; FALSE POSITIVE RESULT; GENERAL PRACTITIONER; HUMAN; LETTER; OVARIECTOMY; OVARY CANCER; OVARY TUMOR; PERFORMANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SYMPTOM; TUMOR BIOPSY; BLOOD; FEMALE; GENERAL PRACTICE; HOSPITAL ADMISSION; LABORATORY DIAGNOSIS; PATIENT REFERRAL;

CA-125 ANTIGEN; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FAMILY PRACTICE; FEMALE; HUMANS; OVARIAN NEOPLASMS; REFERRAL AND CONSULTATION; WAITING LISTS;

EID: 68249109372     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2719     Document Type: Letter

References (4)

1. Reeve G, Mackay-Thomas S. The invisible worm: ovarian cancer. BMJ 2009;338:b2072. (4 June.)[Free Full Text]
2. Tate A, Martin A, Murray-Thomas T, Anderson S, Cassell J. Determining the date of diagnosis - is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care. BMC Medical Research Methodology 2009;9:42.[CrossRef] [Medline]
3. Bankhead C, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, et al. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG 2008;115:1008-14.[CrossRef][Web of Science] [Medline]
4. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 2009;10:327-40.[CrossRef][Web of Science][Medline]